The American academy of pediatrics AAP recommends that all infants receive a new preventive antibody, nirsevimab for protection against respiratory syncytial virus RSV. The antibody should protect infants from serious RSV infection and the need for hospital admission if they get the infection.
Pediatrics – Denali Primary Care